Vicarious Surgical (RBOT) Competitors $12.00 -0.03 (-0.25%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RBOT vs. SMTI, INGN, LAKE, ZJYL, MLSS, SPAI, APT, NTRB, CLGN, and COCHShould you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Safe Pro Group Inc. Common Stock (SPAI), Alpha Pro Tech (APT), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), and Envoy Medical (COCH). These companies are all part of the "surgical appliances & supplies" industry. Vicarious Surgical vs. Sanara MedTech Inogen Lakeland Industries Jin Medical International Milestone Scientific Safe Pro Group Inc. Common Stock Alpha Pro Tech Nutriband CollPlant Biotechnologies Envoy Medical Sanara MedTech (NASDAQ:SMTI) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation. Does the media refer more to SMTI or RBOT? In the previous week, Vicarious Surgical had 1 more articles in the media than Sanara MedTech. MarketBeat recorded 1 mentions for Vicarious Surgical and 0 mentions for Sanara MedTech. Vicarious Surgical's average media sentiment score of 1.94 beat Sanara MedTech's score of 0.00 indicating that Vicarious Surgical is being referred to more favorably in the news media. Company Overall Sentiment Sanara MedTech Neutral Vicarious Surgical Very Positive Do insiders and institutionals hold more shares of SMTI or RBOT? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by company insiders. Comparatively, 11.7% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is SMTI or RBOT more profitable? Vicarious Surgical has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Vicarious Surgical N/A -81.46%-63.62% Which has more risk and volatility, SMTI or RBOT? Sanara MedTech has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Which has preferable valuation and earnings, SMTI or RBOT? Sanara MedTech has higher revenue and earnings than Vicarious Surgical. Sanara MedTech is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$78.06M3.77-$4.30M-$0.99-34.02Vicarious SurgicalN/AN/A-$71.07M-$10.29-1.17 Does the MarketBeat Community favor SMTI or RBOT? Sanara MedTech received 10 more outperform votes than Vicarious Surgical when rated by MarketBeat users. Likewise, 54.55% of users gave Sanara MedTech an outperform vote while only 33.33% of users gave Vicarious Surgical an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% Vicarious SurgicalOutperform Votes833.33% Underperform Votes1666.67% Do analysts rate SMTI or RBOT? Sanara MedTech currently has a consensus target price of $44.00, indicating a potential upside of 30.64%. Vicarious Surgical has a consensus target price of $10.25, indicating a potential downside of 14.58%. Given Sanara MedTech's stronger consensus rating and higher possible upside, research analysts clearly believe Sanara MedTech is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Vicarious Surgical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummarySanara MedTech beats Vicarious Surgical on 12 of the 17 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Vicarious Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RBOT vs. The Competition Export to ExcelMetricVicarious SurgicalSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$70.90M$9.53B$5.14B$19.19BDividend YieldN/A1.38%5.09%3.61%P/E Ratio-1.1719.5689.9741.30Price / SalesN/A32.801,116.2117.58Price / CashN/A22.3742.8921.28Price / Book0.725.494.785.32Net Income-$71.07M$182.72M$120.23M$989.88M7 Day Performance-15.49%-4.48%-1.92%-3.54%1 Month Performance16.62%-4.23%11.49%-3.68%1 Year Performance3.49%-12.17%30.57%12.14% Vicarious Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RBOTVicarious Surgical1.2864 of 5 stars$12.00-0.2%$10.25-14.6%-5.0%$70.90MN/A-1.173SMTISanara MedTech1.9969 of 5 stars$34.02-1.8%$44.00+29.3%-14.5%$297.34M$64.99M-35.0060INGNInogen2.5642 of 5 stars$8.94-0.2%$7.00-21.7%+46.0%$212.93M$331.52M-3.98834Analyst DowngradeNews CoverageLAKELakeland Industries4.5837 of 5 stars$23.74+4.6%$26.50+11.6%+28.5%$175.82M$151.82M-252.221,750Analyst ForecastAnalyst RevisionZJYLJin Medical InternationalN/A$0.78+0.1%N/A-99.0%$120.75M$19.82M0.00245Gap DownMLSSMilestone Scientific2.1612 of 5 stars$0.83+2.6%$1.25+50.4%+54.0%$64.73M$8.88M-11.5730Analyst ForecastNews CoverageSPAISafe Pro Group Inc. Common StockN/A$4.18-6.3%N/AN/A$57.51M$1.56M0.0011News CoveragePositive NewsAPTAlpha Pro TechN/A$5.22-0.6%N/A+3.1%$57.42M$59.29M14.19120NTRBNutriband0.4077 of 5 stars$4.37+5.6%N/A+63.2%$48.53M$2.02M-5.8310Positive NewsGap UpCLGNCollPlant Biotechnologies2.1391 of 5 stars$3.67-0.5%$12.50+240.6%-35.3%$42.02M$10.96M-2.3870Positive NewsCOCHEnvoy Medical3.2104 of 5 stars$1.88-4.1%$8.00+325.5%-26.7%$38.07M$320,000.000.0034News CoverageGap Up Related Companies and Tools Related Companies SMTI Alternatives INGN Alternatives LAKE Alternatives ZJYL Alternatives MLSS Alternatives SPAI Alternatives APT Alternatives NTRB Alternatives CLGN Alternatives COCH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:RBOT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
